4.7 Article

A novel convex acoustic lens-attached ultrasound drug delivery system and its testing in a murine melanoma subcutaneous model

期刊

出版社

ELSEVIER
DOI: 10.1016/j.ijpharm.2023.123118

关键词

Acoustic lens; Ultrasound-mediated microbubble destruction; Drug delivery; Doxorubicin; Melanoma tumor; The authors would like to especially thank Yong Sub Shin (SNUH) for animal modeling and imaging scans

向作者/读者索取更多资源

Target-specific drug release is essential for enhancing chemotherapeutic efficacy. This study proposes a convex acoustic lens-attached US (CALUS) as a simple and efficient alternative to focused ultrasound for drug delivery system (DDS) application. CALUS effectively focuses ultrasound and optimizes acoustic parameters to achieve microbubble destruction and enhance the therapeutic effects of an antitumor drug. In a melanoma mouse model, CALUS exhibited superior tumor growth inhibition, indicating its potential as a treatment approach.
Target-specific drug release is indispensable to improve chemotherapeutic efficacy as it enhances drug uptake and penetration into tumors. Sono-responsive drug-loaded nano-/micro-particles are a promising solution for achieving target specificity by exposing them to ultrasound near tumors. However, the complicated synthetic processes and limited ultrasound (US) exposure conditions, such as limited control of ultrasound focal depth and acoustic power, prevent the practical application of this approach in clinical practice. Here, we propose a convex acoustic lens-attached US (CALUS) as a simple, economic, and efficient alternative of focused US for drug delivery system (DDS) application. The CALUS was characterized both numerically and experimentally using a hydrophone. In vitro, microbubbles (MBs) inside microfluidic channels were destroyed using the CALUS with various acoustic parameters (acoustic pressure [P], pulse repetition frequency [PRF], and duty cycle) and flow velocity. In vivo, tumor inhibition was evaluated using melanoma-bearing mice by characterizing tumor growth rate, animal weight, and intratumoral drug concentration with/without CALUS DDS. US beams were measured to be efficiently converged by CALUS, which was consistent with our simulation results. The acoustic parameters were optimized through the CALUS-induced MB destruction test (P = 2.34 MPa, PRF = 100 kHz, and duty cycle = 9%); this optimal parameter combination successfully induced MB destruction inside the microfluidic channel with an average flow velocity of up to 9.6 cm/s. The CALUS also enhanced the therapeutic effects of an antitumor drug (doxorubicin) in vivo in a murine melanoma model. The combination of the doxorubicin and the CALUS inhibited tumor growth by similar to 55% more than doxorubicin alone, clearly indicating synergistic antitumor efficacy. Our tumor growth inhibition performance was better than other methods based on drug carriers, even without a time-consuming and complicated chemical synthesis process. This result suggests that our novel, simple, economic, and efficient target-specific DDS may offer a transition from preclinical research to clinical trials and a potential treatment approach for patient-centered healthcare.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据